Exact Mass: 491.1301962
Exact Mass Matches: 491.1301962
Found 127 metabolites which its exact mass value is equals to given mass value 491.1301962,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cyanidin 3-(6'-acetyl-galactoside)
Cyanidin 3-(6-acetyl-galactoside) is found in highbush blueberry. Cyanidin 3-(6-acetyl-galactoside) is a constituent of the leaves of Nymphaea alba [CCD] Constituent of the leaves of Nymphaea alba [CCD]. Cyanidin 3-(6-acetyl-galactoside) is found in lowbush blueberry and highbush blueberry.
Cyanidin 3-(4-acetylglucoside)
Cyanidin 3-(4-acetylglucoside) is found in citrus. Cyanidin 3-(4-acetylglucoside) is isolated from oranges. Isolated from oranges. Cyanidin 3-(4-acetylglucoside) is found in sweet orange and citrus.
Birabresib
C25H22ClN5O2S (491.11826620000005)
3,4-Dihydro-6-[[4-[[[3-(methylsulfonyl)phenyl]methyl]amino]-5-(trifluoromethyl)-2-pyrimidinyl]amino]-2(1H)-quinolinone
C22H20F3N5O3S (491.1238886000001)
3-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]-3-fluorophenyl}-1-(2-phenylacetyl)thiourea
C26H22FN3O4S (491.13149840000005)
Cyanidin 3-(6'-acetylglucoside)
Cyanidin 3-(6-acetylglucoside) is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Cyanidin 3-(6-acetylglucoside) is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Cyanidin 3-(6-acetylglucoside) can be found in a number of food items such as highbush blueberry, chives, summer grape, and grape wine, which makes cyanidin 3-(6-acetylglucoside) a potential biomarker for the consumption of these food products.
Cyanidin 3-(6-acetylgalactoside)
Cyanidin 3-(4-acetylglucoside)
N-[(4-beta-L-rhamnopyranosyl)benzyl]-1-O-alpha-D-glucopyranosylthiocarboxamide
C20H29NO11S (491.1461244000001)
Cys Asn Gln Gln
C17H29N7O8S (491.17982340000003)
Cys Gln Asn Gln
C17H29N7O8S (491.17982340000003)
Cys Gln Gln Asn
C17H29N7O8S (491.17982340000003)
Asp Asp Asp Gln
Asp Asp Glu Asn
Asp Asp Gly Trp
Asp Asp Asn Glu
Asp Asp Gln Asp
Asp Asp Trp Gly
Asp Glu Asp Asn
Asp Glu Asn Asp
Asp Gly Asp Trp
Asp Gly Trp Asp
Asp Asn Asp Glu
Asp Asn Glu Asp
Asp Gln Asp Asp
Asp Trp Asp Gly
Asp Trp Gly Asp
Glu Asp Asp Asn
Glu Asp Asn Asp
Glu Asn Asp Asp
Gly Asp Asp Trp
Gly Asp Trp Asp
Gly Trp Asp Asp
Met Asn Asn Asn
C17H29N7O8S (491.17982340000003)
Asn Cys Gln Gln
C17H29N7O8S (491.17982340000003)
Asn Asp Asp Glu
Asn Asp Glu Asp
Asn Glu Asp Asp
Asn Met Asn Asn
C17H29N7O8S (491.17982340000003)
Asn Asn Met Asn
C17H29N7O8S (491.17982340000003)
Asn Asn Asn Met
C17H29N7O8S (491.17982340000003)
Asn Gln Cys Gln
C17H29N7O8S (491.17982340000003)
Asn Gln Gln Cys
C17H29N7O8S (491.17982340000003)
Gln Cys Asn Gln
C17H29N7O8S (491.17982340000003)
Gln Cys Gln Asn
C17H29N7O8S (491.17982340000003)
Gln Asp Asp Asp
Gln Asn Cys Gln
C17H29N7O8S (491.17982340000003)
Gln Asn Gln Cys
C17H29N7O8S (491.17982340000003)
Gln Gln Cys Asn
C17H29N7O8S (491.17982340000003)
Gln Gln Asn Cys
C17H29N7O8S (491.17982340000003)
Trp Asp Asp Gly
Trp Asp Gly Asp
Trp Gly Asp Asp
4-[[5-(acetylamino)-1H-indol-3-yl]methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl]-Benzamide
C26H25N3O5S (491.15148400000004)
(2R,3R)-2,3-dihydroxybutanedioic acid,(2S,3S)-3,4-dimethyl-2-phenylmorpholine
C20H29NO13 (491.16388240000003)
4-thiophen-2-yl-N,N-bis(4-thiophen-2-ylphenyl)aniline
C30H21NS3 (491.08360660000005)
2-(4-(4-(4-(2-chlorophenylcarbamoyl)phenylamino)-5-fluoropyrimidin-2-ylamino)phenyl)acetic acid
Bucladesine sodium
C18H23N5NaO8P (491.11818880000004)
C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CE - Phosphodiesterase inhibitors Bucladesine sodium salt (Dibutyryl-cAMP sodium salt) is a stabilized cyclic AMP (cAMP) analog and a selective PKA activator. Bucladesine sodium salt raises the intracellular levels of cAMP. Bucladesine sodium salt is also a phosphodiesterase (PDE) inhibitor. Bucladesine sodium salt has anti-inflammatory activity and can be used for impaired wound healing[1][2][3][4].
Birabresib
C25H22ClN5O2S (491.11826620000005)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
4,7,8,9-tetra-o-acetyl-n-acetylneuraminic acid methyl ester
C20H29NO13 (491.16388240000003)
(((((1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)Methyl)phosphoryl)bis(oxy))bis(Methylene) isopropyl Methyl dicarbonate
C17H26N5O10P (491.14172260000004)
6-chloro-3-indoxyl-beta-d-cellobioside
C20H26ClNO11 (491.1194316000001)
Fmoc-(S)-3-Amino-4-(pentafluoro-phenyl)-butyric acid
N-(5-Chloro-Benzo[b]thiophen-3-Ylmethyl)-2-[6-Chloro-Oxo-3-(2-Pyridin-2-Yl-Ethylamino)-2h-Pyrazin-1-Yl]-Acetamide
N-(1-dibutoxyphosphoryl-4-oxo-1-naphthalenyl)benzenesulfonamide
C24H30NO6PS (491.1531370000001)
3-Amino-2-[(4-methoxyanilino)-oxomethyl]-4-(4-methoxyphenyl)-6-methyl-5-thieno[2,3-b]pyridinecarboxylic acid ethyl ester
C26H25N3O5S (491.15148400000004)
2-[[2-[[4-(2-Methoxyethyl)-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]thio]-1-oxoethyl]amino]-4-methyl-5-thiazolecarboxylic acid ethyl ester
[4-Amino-2-[2-methoxy-4-(4-methyl-1-piperazinyl)anilino]-5-thiazolyl]-(2,6-dichlorophenyl)methanone
2-{(E)-[2-({[4-(4-chlorophenyl)-5-phenyl-4H-1,2,4-triazol-3-yl]sulfanyl}acetyl)hydrazinylidene]methyl}benzoic acid
N-[3-[4-(4-fluorophenyl)-1-piperazinyl]-1,4-dioxo-2-naphthalenyl]benzenesulfonamide
C26H22FN3O4S (491.13149840000005)
6-amino-5-cyano-2-[[(3-cyano-6-methyl-7,8-dihydro-5H-1,6-naphthyridin-2-yl)thio]methyl]-4-(4-fluorophenyl)-4H-pyran-3-carboxylic acid methyl ester
2-[[2-(Cyclohexylamino)-2-oxo-1-thiophen-2-ylethyl]-[1-oxo-2-[[oxo(thiophen-2-yl)methyl]amino]ethyl]amino]acetic acid ethyl ester
C23H29N3O5S2 (491.15485440000003)
(2R,3R,3aS,9bS)-N-[(2-chlorophenyl)methyl]-3-(hydroxymethyl)-1-methylsulfonyl-6-oxo-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C23H26ClN3O5S (491.1281616000001)
(2S,3S,3aR,9bR)-N-[(2-chlorophenyl)methyl]-3-(hydroxymethyl)-1-methylsulfonyl-6-oxo-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C23H26ClN3O5S (491.1281616000001)
2-propan-2-yloxyethyl 4-(6-bromo-1,3-benzodioxol-5-yl)-2-methyl-5-oxo-4,6,7,8-tetrahydro-3H-quinoline-3-carboxylate
C23H26BrNO6 (491.09433960000007)
(2S,3S,4S,5R)-6-[3-[(4-aminophenyl)sulfonylamino]-2-phenylpyrazol-1-ium-1-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid
4-azido-5-iodo-2-methoxy-N-[2-methyl-1-(phenylmethyl)-3-pyrrolidinyl]benzamide
PF-573228
C22H20F3N5O3S (491.1238886000001)
cyanidin 3-O-(6-O-acetyl-beta-D-glucoside)
An anthocyanin cation consisting of cyanidin having a 6-O-acetyl-beta-D-glucosyl residue attached at the 3-hydroxy position.
IGUANA-1
C27H26ClN3O4 (491.1611746000001)
IGUANA-1 is a potent inhibitor of ALDH1B1, which is a mitochondrial enzyme that promotes colorectal and pancreatic cancer. IGUANA-1 has significant inhibition against cancer cells[1].
(2s)-3-(3-chloro-4-methoxyphenyl)-2-{[(2e,5s,6s,7r,8s)-1,5,7,8-tetrahydroxy-6-methyl-8-phenyloct-2-en-1-ylidene]amino}propanoic acid
C25H30ClNO7 (491.17107000000004)
4-ethenyl-7,8-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C24H29NO10 (491.17913740000006)
3,5,21,24,28-pentahydroxy-7-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2(11),3,5,7,9,17,20(25),27-nonaen-26-one
(1s,9r,11e,19z,22r)-3,9,18-trihydroxy-15-methoxy-22-methyl-6,23-dioxa-26-thia-2,17,27-triazatricyclo[17.5.2.1⁴,⁷]heptacosa-2,4,7(27),11,13,17,19-heptaen-24-one
C23H29N3O7S (491.17261240000005)
3,9,18-trihydroxy-11-methoxy-22-methyl-6,23-dioxa-26-thia-2,17,27-triazatricyclo[17.5.2.1⁴,⁷]heptacosa-2,4,7(27),12,14,17,19-heptaen-24-one
C23H29N3O7S (491.17261240000005)
3-(3-chloro-4-methoxyphenyl)-2-[(1,5,7,8-tetrahydroxy-6-methyl-8-phenyloct-2-en-1-ylidene)amino]propanoic acid
C25H30ClNO7 (491.17107000000004)
(s)-{[(2s,3s,4s)-2-amino-1,3,4-trihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-5-methyl-2-oxopyrimidin-1-yl)oxolan-2-yl]acetic acid
n-[(2r,3s,4r,6r)-3-hydroxy-2-methyl-6-(1,6,8-trihydroxy-3-methyl-7,12-dioxotetraphen-5-yl)oxan-4-yl]ethanimidic acid
{[2-amino-1,4-dihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}[(2r,3s,4r,5r)-3,4-dihydroxy-5-[4-hydroxy-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]oxolan-2-yl]acetic acid
(13r,21r,24s)-3,5,21,24,28-pentahydroxy-7-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2(11),3,5,7,9,17,20(25),27-nonaen-26-one
3,9,18-trihydroxy-15-methoxy-22-methyl-6,23-dioxa-26-thia-2,17,27-triazatricyclo[17.5.2.1⁴,⁷]heptacosa-2,4,7(27),11,13,17,19-heptaen-24-one
C23H29N3O7S (491.17261240000005)
(4s)-2-(6-chloro-4-hydroxy-1-methylindol-3-yl)-n-[(1s)-2-hydroxy-2-[(methoxycarbonyl)imino]-1-[(2r)-pyrrolidin-2-yl]ethyl]-4-methyl-5h-1,3-oxazole-4-carboximidic acid
C22H26ClN5O6 (491.1571526000001)
n-[3-hydroxy-2-methyl-6-(1,6,8-trihydroxy-3-methyl-7,12-dioxotetraphen-5-yl)oxan-4-yl]ethanimidic acid
(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 1-sulfanyl-n-[(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)methyl]methanimidate
C20H29NO11S (491.1461244000001)
(1s,17s,24r,25r)-25-[(1r)-1,2-dihydroxyethyl]-1,4,11,24,25-pentahydroxy-16-azahexacyclo[15.7.1.0²,¹⁵.0⁵,¹⁴.0⁷,¹².0¹⁸,²³]pentacosa-2,4,7,9,11,14,18,20,22-nonaene-6,13-dione
25-(1,2-dihydroxyethyl)-1,4,11,24,25-pentahydroxy-16-azahexacyclo[15.7.1.0²,¹⁵.0⁵,¹⁴.0⁷,¹².0¹⁸,²³]pentacosa-2,4,7,9,11,14,18,20,22-nonaene-6,13-dione
3-{[(2s,3r,4s,5s,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-1λ⁴-chromen-1-ylium
(3s,4s,4as,5ar)-4-ethenyl-7,8-dihydroxy-3-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C24H29NO10 (491.17913740000006)
(1s,9r,11s,14e,19z,22r)-3,9,18-trihydroxy-11-methoxy-22-methyl-6,23-dioxa-26-thia-2,17,27-triazatricyclo[17.5.2.1⁴,⁷]heptacosa-2,4,7(27),12,14,17,19-heptaen-24-one
C23H29N3O7S (491.17261240000005)
2-(6-chloro-4-hydroxy-1-methylindol-3-yl)-n-{2-hydroxy-2-[(methoxycarbonyl)imino]-1-(pyrrolidin-2-yl)ethyl}-4-methyl-5h-1,3-oxazole-4-carboximidic acid
C22H26ClN5O6 (491.1571526000001)
{[2-amino-1,4-dihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}({3,4-dihydroxy-5-[4-hydroxy-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]oxolan-2-yl})acetic acid
3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 1-sulfanyl-n-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)methanimidate
C20H29NO11S (491.1461244000001)